WallStSmart
KLRS

Kalaris Therapeutics, Inc.

NASDAQ: KLRS · HEALTHCARE · BIOTECHNOLOGY

$5.52
+0.18% today

Updated 2026-04-30

Market cap
$138.41M
P/E ratio
P/S ratio
EPS (TTM)
$-2.85
Dividend yield
52W range
$2 – $12
Volume
0.1M

Kalaris Therapeutics, Inc. (KLRS) Earnings

Quarterly earnings history, analyst estimates, and stock price reaction.

EPS beat streak
4 of 8
Last 8 quarters
Avg EPS surprise
-45.7%
Last 4 quarters
Revenue YoY growth
Most recent quarter
EPS YoY growth
+86.6%
Most recent quarter

Earnings surprise history (last 12 quarters)

Beat estimate Missed estimate

Quarterly EPS and revenue trend

Quarterly revenue EPS (diluted)

How the stock reacts to earnings

Avg 1-day reaction
-4.7%
Last 2 reports
Positive reaction rate
50%
1 of 2 quarters
Largest single-day move
-14.5%
2026-03-17
Report dateEPS actualSurpriseClose beforeClose after1-day reaction
2026-03-17$-0.44+20.0%$8.81$7.53-14.5%
2025-11-12$-0.64-4.5%$5.07$5.33+5.1%

Quarterly earnings history

Fiscal quarter endingEPS estimateEPS actualSurpriseRevenueYoY revenue
2025-12-31$-0.55$-0.44+20.0%
2025-09-30$-0.61$-0.64-4.5%
2025-06-30$-0.62$-0.61+1.6%
2025-03-31$-0.77$-2.52-227.3%
2024-12-31$-0.12$-3.28-2633.3%
2024-09-30$-0.10$-0.82-765.6%
2024-06-30$-0.05$-0.05+0.0%
2024-03-31$-0.26$-0.26+0.0%
2023-12-31$-0.52$-0.52+0.0%
2023-09-30$-0.39$-0.39+0.0%
2023-06-30$-0.48$-0.48+0.0%
2023-03-31$-0.47$-0.44+6.4%

Frequently asked questions

Has Kalaris Therapeutics, Inc. beaten earnings estimates?
Kalaris Therapeutics, Inc. has beaten Wall Street EPS estimates in 4 of its last 8 quarterly reports, with an average EPS surprise of -45.7% over the last 4 quarters.
How does KLRS stock react to earnings?
KLRS stock has moved an average of -4.7% in the trading day following earnings over its last 2 reports, with positive reactions in 50% of those quarters.